Provided by Tiger Fintech (Singapore) Pte. Ltd.

Urovant Sciences Ltd.

16.24
0.0000
Volume:- -
Turnover:- -
Market Cap:531.75M
PE:-3.09
High:16.24
Open:16.24
Low:16.24
Close:16.24
Loading ...
Mar 30, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 29, 2021

Privatisation

SC 13E3/A [Amend] - Going private transaction by certain issuers
Mar 29, 2021

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 29, 2021

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 29, 2021

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 29, 2021

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Mar 29, 2021

Major Issues Report

8-K - Current report
Mar 24, 2021

Major Issues Report

8-K - Current report
Feb 19, 2021

Privatisation

SC 13E3/A [Amend] - Going private transaction by certain issuers
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 12, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Major Issues Report

8-K - Current report
Feb 09, 2021

Privatisation

SC 13E3/A [Amend] - Going private transaction by certain issuers
Feb 09, 2021

Major Issues Report

8-K - Current report
Dec 29, 2020

Privatisation

SC 13E3 - Going private transaction by certain issuers
Dec 23, 2020

Major Issues Report

8-K - Current report
Nov 24, 2020

Major Issues Report

8-K - Current report
Nov 17, 2020

Major Issues Report

8-K - Current report
Nov 13, 2020

Major Issues Report

8-K - Current report